Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction

Summary

The objective of the study is to compare the pharmacokinetics profiles and safety of Evogliptin in patients wit hepatic dysfunction versus healthy volunteers after single oral dose of Evogliptin

Timeline

Start

2016-09-22

Primary completion

2018-01-19

Completion

2018-01-19

Drugs

Indications